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Abstract
Pax6 encodes a specific DNA-binding transcription factor that regulates the development of multiple organs, including the
eye, brain and pancreas. Previous studies have shown that Pax6 regulates the entire process of ocular lens development. In
the developing forebrain, Pax6 is expressed in ventricular zone precursor cells and in specific populations of neurons;
absence of Pax6 results in disrupted cell proliferation and cell fate specification in telencephalon. In the pancreas, Pax6 is
essential for the differentiation of a-, b- and d-islet cells. To elucidate molecular roles of Pax6, chromatin
immunoprecipitation experiments combined with high-density oligonucleotide array hybridizations (ChIP-chip) were
performed using three distinct sources of chromatin (lens, forebrain and b-cells). ChIP-chip studies, performed as biological
triplicates, identified a total of 5,260 promoters occupied by Pax6. 1,001 (133) of these promoter regions were shared
between at least two (three) distinct chromatin sources, respectively. In lens chromatin, 2,335 promoters were bound by
Pax6. RNA expression profiling from Pax6+/2 lenses combined with in vivo Pax6-binding data yielded 76 putative Pax6-direct
targets, including the Gaa, Isl1, Kif1b, Mtmr2, Pcsk1n, and Snca genes. RNA and ChIP data were validated for all these genes.
In lens cells, reporter assays established Kib1b and Snca as Pax6 activated and repressed genes, respectively. In situ
hybridization revealed reduced expression of these genes in E14 cerebral cortex. Moreover, we examined differentially
expressed transcripts between E9.5 wild type and Pax62/2 lens placodes that suggested Efnb2, Fat4, Has2, Nav1, and Trpm3
as novel Pax6-direct targets. Collectively, the present studies, through the identification of Pax6-direct target genes, provide
novel insights into the molecular mechanisms of Pax6 gene control during mouse embryonic development. In addition, the
present data demonstrate that Pax6 interacts preferentially with promoter regions in a tissue-specific fashion. Nevertheless,
nearly 20% of the regions identified are accessible to Pax6 in multiple tissues.
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Background
A fundamental feature of gene regulation during embryonic
development is an extensive utilization of combinatorial mecha-
nisms that ensure proper temporal and spatial control of gene
expression [1]. The majority of transcription factors that regulate
embryonic development are expressed in multiple tissues [2]. The
combinatorial regulatory mechanism at the ‘‘ground’’ level
employs specific combinations of lineage-restricted sequence-
specific DNA-binding transcription factors to control cell-specific
gene regulatory networks [3,4,5]. The emergence of ChIP-chip
and ChIP-seq technologies to identify regions of chromatin
occupied in vivo by specific transcription factors, to map local
chromatin structure, and to assess long-range interactions between
specific regions of chromatin allows novel insights into the process
of gene regulation [6].
Pax6 (paired box 6) is a lineage-specific DNA-binding
transcription factor that regulates development of the central
nervous system, endocrine pancreas, eye and olfactory system
[7,8,9,10,11,12,13]. A series of studies implicated Pax6 and its
homologues (e.g. Drosophila eyeless (ey) and eye gone (Eyg), zebrafish
Pax6a and Pax6b) and related (jellyfish Pax-A and Pax-B) genes as
central molecules responsible for the evolution of visual systems in
vertebrates and invertebrates [14,15,16,17]. Consequently, a
number of mouse and human developmental defects and
neurological disorders have been attributed to mutations in
Pax6/PAX6 genes [18,19]. Thus, understanding of genetic
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networks downstream of Pax6 genes is essential for better
understanding of embryonic development and mechanism of
human congenital diseases.
In the lens, Pax6 serves as an essential gene for the formation of
lens progenitor cells. In the absence of Pax6, the lens placode is not
formed [20,21]. In subsequent stages, Pax6 regulates lens
morphogenesis during lens vesicle formation [22,23,24], the
withdrawal of primary lens fiber cells from the cell cycle and
their terminal differentiation [25,26,27,28,29]. In the developing
brain, Pax6 controls neurogenesis, patterning and proliferation in
neuroepithelial and radial glia progenitor cells [12]. In addition,
Pax6 is required for adult neurogenesis, and dopaminergic
olfactory bulb interneuron specification and survival [30,31,32].
In the pancreas, Pax6 controls the formation of islets, the number
of endocrine cells, in particular a- and b- cells. Pax6 directly
regulates key functional genes, including glucagon, glucose
transporter 2, insulin and somatostatin [33,34,35,36,37,38].
Recent comparative RNA profiling studies showed that Pax6
regulates expression of selected common genes in lens and in
embryonic forebrain [26]. Specifically, Pax6 directly controls
expression of aA-crystallin in lens [39] and in olfactory bulb
dopaminergic neurons [32] via shared but not identical molecular
mechanisms. Thus, these findings raise the interesting possibility
that some Pax6-target genes are common between multiple tissues
while other targets are tissue-specific.
Considering the central role of Pax6 in eye formation, it has
been estimated that Drosophila ey ultimately controls the expression
of several thousand genes [40,41,42]. However, the proportion of
directly or indirectly regulated genes is not known, as the majority
of Pax6-direct targets in different tissues and at specific develop-
mental stages remain to be determined [26,43,44]. To begin
answering these questions, we performed comparative chromatin
immunoprecipitation (ChIP) studies with Pax6-specific antibodies
using chromatin prepared from newborn mouse lens, E15
forebrain and cultured pancreatic b-cells. To identify genes
regulated by Pax6, we performed analysis of transcripts expressed
in the wild type lens placode and compared them with genes
expressed in Pax62/2 surface ectoderm. In addition, we used
earlier published data on differential gene expression between wild
type and Pax6+/2 lenses [26] as well as wild type and Pax62/2
embryonic cortex [26,45]. These studies identified a series of novel
Pax6 direct target genes, with Kif1b and Snca characterized at
both the cellular and molecular levels.
Results
Identification of Pax6-bound regions in lens, forebrain
and b-cell chromatin
We reasoned that parallel studies of multiple tissues/cells
regulated by Pax6, such as lens, forebrain and cultured b-cells of
pancreas, would increase our power to identify tissue-specific as
well as shared Pax6-dependent regulatory pathways. To identify
regions occupied by Pax6 in chromatin prepared from newborn
lenses, E15 forebrain and pancreatic b-cells, we used GeneChip
Mouse Promoter 1.0R Arrays (Affymetrix), which contain over
28,000 mouse promoters. Each promoter region covers approx-
imately 6 kb upstream and 2.5 kb downstream of the transcription
start site(s). Three biological replicates were performed using each
tissue. The data were analyzed using Model-based Analysis of
Tiling-arrays [46] using a MAT score of 4.0 as the cutoff. We
found a total of 5,260 regulatory elements occupied by Pax6. In
individual materials, we found 2,335, 2,484 and 1,270 Pax6-
bound promoters in lens, forebrain and b-cells chromatins,
respectively (Figure 1 and Table S1). The Venn diagram
(Figure 1A) shows that a total number of 133 genes had their
promoter regions bound by Pax6 in the three tissues. Commonly
occupied promoter regions were also found between the lens and
cortex (n = 515), lens and b-cells (n = 181) and cortex and b-cells
(n = 172). The total number of genes/promoters occupied by Pax6
in at least two tissues was 1,001, representing ,20% of all genes/
promoters bound by Pax6.
To further characterize these 133 genes, we investigated their
ontology and presence of the Pax6 DNA-binding motifs within the
bound regions. The largest GO categories, olfactory receptor
activity, sensory perception of chemical stimulus and sensory
perception of smell, include 15 genes encoding olfactory receptors
(Figure 1B). Interestingly, only four from the set of 133 genes were
previously identified as Pax6-regulated genes: Gaa, Nav1, Otx2 and
Snca [26,45,47]. To identify the putative Pax6-binding sites, we
employed a recently established set of ten Pax6-binding site motifs
[48]. These DNA motifs represent a continuum of related
sequences presumably recognized by different combinations of
the Pax6 protein structural motifs identified via crystallographic
studies. These include the b-turn, PAI, linker, RED and
homeodomain (HD) [49,50]. These DNA motifs were converted
into position-specific scoring matrices using the Python program
and the potential binding sites were found by a software prediction
tool, Find Individual Motif Occurrences (FIMO) [51]. A total of
324 unique binding sites were identified (Figure 1C). Each of these
individual motifs predicted a comparable number of putative
Pax6-binding sites (median 30, range 13 to 56) in approximately
80% of the ‘‘peak’’ regions examined (Figure 1C).
Identification of direct Pax6 target genes in lens
development
To find candidate genes for direct regulation by Pax6 in lens, we
first compared the 2,335 Pax6-peaks identified in newborn lens
chromatin (Table S1) with 559 genes differentially expressed in
Pax6 heterozygous lenses (accession number GSE13244) of the
same developmental stage identified earlier [26]. This analysis
revealed 53 down- and 23 up-regulated genes (Figure 2). The
relatively low number of overlapping genes (n = 76) could be
explained by the fact that the RNA expression profiling identified
genes sensitive only to Pax6 haploinsufficiency.
To identify genes whose expression is dependent on both copies
of Pax6, we performed conditional inactivation of Pax6 in the lens
placode using the Le-Cre system [20]. In Pax6 null embryos, lens
placodes are not formed [52]. Using the laser microdissection in
combination with RNA expression profiling detected by Illumina
Mouse WG-6 V1 1 R4 expression BeadChips, we identified
several hundreds candidates of differentially expressed transcripts
between the wild type lens placode and Pax62/2 surface ectoderm
(E9.5) as described in Materials and Methods. Figure 3A shows a
list of 27 candidate genes that were selected according to their
established or prospective roles in lens placode morphogenesis,
and identified as differentially expressed in Pax6 null embryonic
cortex [45]. Identification of Pax6 ‘‘peaks’’ in E15 cortex
chromatin and multi-tissue chromatin further supports the idea
that a majority of these genes (19/27) are directly regulated by
Pax6 in lens, although distinct biological materials were analyzed
(E9.5 lens placodes for RNA, and newborn lenses for chromatin
studies). For example, c-Maf, MafB, Pax6, Sfrp2, Tnc and Vcan/
Cspg2 were previously identified as direct Pax6 targets in the lens
[26,36,48,53,54]. Previously, we have shown down-regulation of c-
Maf and Pax6 in the Pax6 null ectoderms [48]. Expression of Fat4,
Trpm3, Pax6, Has2, Efnb2 and Nav1 was evaluated using qRT-
PCR as shown in Figure 3B. Taken together, these results suggest
five novel direct targets of Pax6 in lens.
Novel Direct Targets of Pax6 in Lens and Forebrain
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Figure 1. Pax6-occupied peaks in chromatin prepared from lens, cortex and pancreatic b-cells. (A) Venn diagram showing number of
peaks occupied by Pax6 in lens, cortex and b-cell chromatin. (B) The gene ontology (GO) classification of 133 genes that are occupied by Pax6 in all
three chromatins. (C) Analysis of distribution of ten novel Pax6-binding site motifs in Pax6 peaks at the 133 gene loci, through FIMO (Find Individual
Motif Occurrences) predictive tool.
doi:10.1371/journal.pone.0054507.g001
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We next asked if genes containing Pax6 co-occupied promoters
show any special feature related to their expression levels in
different tissues, and how many of them are regulated by Pax6. It
has been proposed that functionally significant binding of
transcription factor correlates with expression levels of surround-
ing genes [6]. To follow this point, we performed RNA expression
profiling using the same tissues probed in the ChIP-chip studies
(P1 lens, E15 cortex and b-cells). In addition, we included mouse
embryonic stem (ES) cells, as a ‘‘reference’’ tissue for the origin of
embryonic development, and Pax6-positive radial glia progenitors
generated from mouse ES cells [55]. Three sets of biological
replicates were used for RNA expression profiling of these five
tissues/cells measured by microarray hybridization with Affyme-
trix Mouse Genome 430A 2.0 Arrays. Principal component
analysis was performed and nearly 88% of the information was
explained with three principal components (Figure S1A). The
analysis showed that lens, forebrain and b-cell transcriptomes are
distinct, with lens being closer to the forebrain than to b-cells. We
next performed RNA expression analysis with data normalized to
the expression levels in mouse ES cells. Analysis of transcripts
linked to the 133 commonly occupied promoter regions identified
above revealed that ,90% of these genes undergo strong up- or
down-regulation in all three tissues examined (Figure S1B).
Concerning the question whether these genes are regulated by
Pax6, we found 11 genes: Cenpn, Gaa and Snca (Figure 2 and Figure
S1B), and Adprhl2, Cap1, Cma2, Dpm2, Hook2, Rffl, Sra1 and Trove2
(Figure S1B). In addition, Otx2, a gene regulated by Pax6 in the
optic cup [47], is present in the list of 133 common genes, but was
not identified through RNA expression profiling in lens. It is
interesting to note that all 12 genes are highly regulated relative to
their expression in ES cells, consistent with the view that Pax6
establishes novel cell lineages and controls cell differentiation
[56,57,58]. From these data we conclude that, as expected,
transcriptomes of these tissues/cells are globally different between
lens, forebrain and b-cells. The genomic regions with Pax6
presence in all three types of chromatin are mostly linked to genes
activated or repressed in differentiated cell types, compared to
their expression levels in ES cells. Although the present data
suggest that only 12 (9%) of these genes are Pax6-direct targets,
they represent a pool of genes that could be regulated by Pax6 in
many other developmental conditions in addition to those
examined here (newborn lens and E9.5 lens placode).
Kif1b and Snca are novel Pax6 direct target genes in lens
and forebrain
We next focused on the analysis of 76 genes (Figure 2) identified
by RNA and ChIP-chip in newborn lens. Gaa (acid glucosidase a),
Kif1b (kinesin family member 1B) and Pcsk1n (proprotein
convertase subtilisin/kexin type 1 inhibitor) were activated by
Pax6 in the lens, while Isl1 (islet-1), Mtmr2 (myotubularin related
protein 2) and Snca (a-synuclein) were repressed by Pax6 in the
lens. These genes were selected for further validation, as Gaa,
Kif1b, Isl1 and Snca are also regulated by Pax6 in embryonic cortex
[44,45], Mtmr2 and Pcsk1n have strong expression in the mouse
retina, and all regulatory elements for these genes have multiple
putative Pax6-binding sites (summarized in Figures S2 and S3). In
this group of six genes, Gaa and Snca showed Pax6 peaks in all
three chromatin samples (Figures 1A and S3B). Isl1 and Kif1b
displayed Pax6-bound peaks in lens and b-cells, while Mtmr2 and
Pcsk1n showed peaks in lens chromatin only (Figures 1 and S2A).
To validate the RNA expression data, we performed quantitative
RT-PCR of these six genes (Figure 4A). Reduced Pax6 expression
in Pax6+/2 lenses is shown as a control. The data confirmed that
expression of these genes is dependent on Pax6. To validate Pax6
binding in promoter regions of these genes, quantitative ChIPs
(qChIPs) were performed using primers corresponding to the
‘‘peak’’ regions (Figure S2) and surrounding non-specific regions
(NSR) in the same locus. The mouse Cryaa gene promoter and the
+6 kb regions were used as positive and negative controls
respectively [39]. The results confirmed selective binding of
Pax6 at all genomic regions identified by the ChIP-chip data
except for the region ISL1-B at 25 kb of the Isl1 locus (compare
Figure 4B and Figure S2A). IgG control included in the
Figure 2. Identification of genes regulated by Pax6 in newborn lens. Venn diagram showing identification of 76 genes both bound and
regulated by Pax6 by intersecting two genome-wide data sets: RNA expression profiling (559 transcripts, P1 lens, Pax6+/2 versus wild type) [26] and
present ChIP-chip studies (2,335 peaks) (Table S1) in lens chromatin. The table summarized the known function of six important and validated Pax6
direct target genes from this group of 76 genes (see Figure 4) [75,121,122,123,124,125].
doi:10.1371/journal.pone.0054507.g002
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Figure 3. Twenty-seven genes relevant to lens placode formation and lens morphogenesis show differential expression in Pax62/2
E9.5 mutated lens placodes. (A) A list of 27 genes includes a combination of well-characterized genes in lens biology and selected differentially
expressed genes in Pax6 null (Sey) cortex [45]. The differentially expressed genes in Pax62/2 E9.5 wild type and mutated lens placodes were identified
using the Illumina Mouse6 bead microarrays as described elsewhere [96]. Twenty-four of the 27 genes were differentially expressed in at least 50% of
experiments. (B) Relative expression levels of Fat4, Trpm3, Pax6, Has2, Efnb2, and Nav1 in wild type (WT, black bars) and Pax62/2 (open bars) lens
placode and mutated ectoderm were determined using qRT-PCR as described in Methods.
doi:10.1371/journal.pone.0054507.g003
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experiments shows random background binding to these regions
tested (Figure S4).
To further test whether Gaa, Isl1, Kif1b, Mtmr2, Pcsk1n, and Snca,
are regulated by Pax6, we performed co-transfection studies in cultured
P19 embryonic carcinoma and aTN4-1 lens epithelial cells. Eleven
luciferase reporter constructs were co-transfected with Pax6. Pax6-
binding regions, identified by ChIP-chip studies, pointed to multiple
regulatory regions such as proximal promoters and distal regions, the
putative enhancers. We found that Kif1b promoter and Snca promoter/
enhancer were activated by Pax6 in P19 cells (Figures 5C and 6B). The
Kif1b promoter was also activated in cultured lens epithelial cells
(Figures 5C). In contrast, the Snca promoter/enhancer reporter plasmid
was repressed by Pax6 in the cultured lens epithelial cells (Figure 6B).
This finding is consistent with increased expression of Snca in Pax6
heterozygous lenses (Figure 4A). To test which parts of Pax6 molecule
are involved in Pax6-mediated reporter gene activation and repression,
we used a panel of four mutants, N50K, R128C, R242T and R317X,
as shown in Figure 5B. Studies of Kif1b promoter show reduced
activation by N50K and R242T mutants (Figure 5C) consistent with
the presence of PAI and HD motifs in site 1 and 2, respectively
(Figure 5D). Activation of Snca promoter/enhancer in P19 cells was
reduced by all four mutants tested in agreement with complex nature
of sites 1, 3 and 4 (Figure 6C). In contrast, transcriptional repression of
this reporter gene construct required the presence of C-terminal
domain (Figure 6B, data for R317X). The remaining four reporter
genes (Gaa, Isl1, Mtmr2 and Pcsk1n) were regulated by Pax6 within a
range of 10–25% (data not shown). Next, we performed EMSAs with
multiple binding sites identified in the Kif1b (Figures 5D and E) and Snca
Pax6-binding regions, respectively (Figures 6C and D). The data
showed binding of recombinant Pax6 proteins to two probes at the
Kif1b locus and three probes at Snca locus. Use of specific
Figure 4. Verification of microarray results by qRT-PCR and qChIP. (A) Relative expression levels of Gaa, Has2, Isl1, Kif1b, Mtmr2, Pax6, Pcsk1n,
and Snca in wild type (WT, shown in black) and Pax6+/2 (shown in gray) lenses were determined using qRT-PCR as described in Methods. B2m, Hprt
and Ccni transcripts were tested as internal references, and all were found unchanged between the WT and Pax6+/2 lenses. The data are expressed
relative to the unchanged expression level of B2m transcripts. For statistical evaluation of the results, p-values were calculated from paired Student t-
tests. (B) Validation of Pax6-binding regions in lens chromatin by qChIPs. A and B are distal regions with Pax6 binding identified in ChIP-Chip
experiments and P regions are binding regions around the proximal promoters. At each of these gene loci, a non-specific region (negative signals in
ChIP-Chip experiments and no candidate Pax6 binding sites predicted) was also included as a negative control. In addition, Cryaa promoter (Cryaa-P)
and +6 kb region serve as positive and negative controls respectively. The specific enrichments of Pax6 binding were detected at Isl1-A, Mtmr2-A,
Snca-A, Gaa-P, Kif1b-P, Pcsk1n-B and Pcsk1n-A regions. The calculation of the cutoff value (0.100 of 1% input) for background signals and specific
binding signals is described in Materials and Methods.
doi:10.1371/journal.pone.0054507.g004
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oligonucleotide competitors confirmed the formation of specific Pax6-
DNA complexes.
Finally, we performed in situ hybridization to evaluate the
expression of Kif1b and Snca in the telencephalon of embryonic
day 14 wild type (WT) and Pax6 null (Sey/Sey) mice. Notably, we
detected both of these transcripts in the ventricular zone (VZ) of
the WT cerebral cortex (Figures 7A and C), where Pax6
expression is highest, and this signal was virtually lost in Sey/Sey
littermates (Figures 7B and D). Interestingly, Kif1b expression is
not affected in the VZ of the neighboring lateral ganglionic
eminence (Figures 7A and B), which expresses lower levels of Pax6
in WT. We suggest that Kif1b and Snca are directly regulated by
Pax6 in lens and forebrain.
Discussion
In this study, we focused on two questions central to
understanding embryonic development: 1) Where are lineage-
specific DNA-binding transcription factors, commonly expressed
in different tissues, localized in chromatin from different tissues,
and 2) which genes are directly regulated by the lineage-specific
regulatory gene, Pax6, in the lens and forebrain? Answering these
questions is important to understand the relationship between the
binding of lineage-specific transcription factors in chromatin from
different tissues and for the identification of developmental
programs directly controlled by Pax6.
Functional Pax6-binding in chromatin: Primary and
secondary Pax6 target genes
Our data identified 133 promoter regions occupied by Pax6 in
chromatin obtained from the lens, forebrain and pancreatic b-
cells. We also found 868 genes that were occupied by Pax6 in two
of these tissues. In summary, 1,001 genes (nearly 1/5 of genes
recognized by Pax6) are co-regulated in these tissues. These data
show that Pax6 binds to common genomic regions in different
Figure 5. Pax6 regulates expression of Kif1b. (A) Identification of Pax6-binding regions by ChIP-Chip in lens chromatin and a corresponding
luciferase reporter construct for transfection assays. (B) A diagrammatic summary of Pax6 mutants, N50K, R128C, R242T and R317X. b, N-terminal b-
turn unit; PD, paird domain; PAI, N-termianl subdomian of PD; RED, C-terminal subdomian of PD; L, linker region; HD, homeodomain; PST, proline-
serine-threonine rich transactivation domain. (C) Pax6 activates Kif1b promoter in cultured cells. Transient transfections were performed in P19
embryonic carcinoma and in aTN4-1 lens cell as described in Methods. (D) Prediction of Pax6 binding sites with novel Pax6 DNA binding motifs [48].
(E) EMSA validation of Pax6 binding to two probes identified by motifs 2-2 and 4-1. PD/HD, recombinant Pax6 protein containing both Pax6 paired
domain (PD) and homeodomain (HD). P6CON, DNA-binding concensus for Pax6 paired domain.
doi:10.1371/journal.pone.0054507.g005
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cellular contexts. These tissues represent distinct cell types, as
further shown here by analysis of their transcriptomes. The
combination of RNA expression profiling with ChIP-chip results
yielded a relatively small number of candidate direct target genes,
compared to the number of genes occupied by Pax6. The simplest
interpretation is that RNA profiling identifies a mixture of primary
(direct, 14% in newborn lens) and secondary (indirect) targets with
the number of secondary targets exceeding the number of direct
target genes. Nevertheless, there may be at least four reasons that
explain the relatively low number of the directly regulated genes.
First, the RNA analysis in Pax6 heterozygous lenses identified only
those genes that are sensitive to Pax6 haploinsufficiency. A
conditional gene approach to delete Pax6 at the lens vesicle/
primary lens fiber cell formation (E12.5) could resolve this problem
[25]. However, an ideal experiment to analyze appropriate
chromatin from E12.5 primitive lens is technically challenging
due to tissue microdissection and limited amount of chromatin
obtained from small embryonic tissue. Second, the promoter
ChIP-chip arrays restricted the analysis, because distal enhancers,
which are major regulatory elements of tissue-specific and tissue-
preferred genes, were not spotted on these arrays. This limitation
is now fully addressable using ChIP-seq analysis [59]. Third, a
significant fraction of the genome is occupied by specific
transcription factors without any obvious regulatory function on
known genes [6] as shown recently for retinoic acid nuclear
receptors [60], MyoD and Myogenin [61], and the glucocorticoid
receptor [62]. Finally, 10–20% of ChIP-chip and ChIP-seq data
detect indirect interactions between the transcription factor and
DNA [63].
On the other hand, the numbers of Pax6-bound promoters in
lens, forebrain and b-cell chromatin appear relatively high
compared to the total number of potentially transcriptionally
active genes. It is possible that the current ChIP-chip data are
partially compromised by a non-specific background signal. We
could not fully address this question in the current study, however,
many Pax6-binding regions were independently validated includ-
ing six genes, Gaa, Isl1, Kif1b, Mtmr2, Pcsk1n, and Snca, shown
here (Figure 4B), and five additional genes, Vcan/Cspg2,
Mab21l2, Olfm3, Spag5 and Tgfb2 examined earlier [26].
Typically, genes selected for validation by qChIP are biased
towards better understanding of Pax6-dependent gene regulatory
networks. A recent ChIP-seq study using two sequential immuno-
precipitations to identify binding of Pax3 and Pax7 in adult
myoblasts revealed over 52,683 (4,648) loci enriched for Pax7
(Pax3), respectively [64]. Both Pax3 and Pax7 are structurally
similar to Pax6. These findings suggest that Pax proteins,
containing the internal homeodomain (HD), can recognize over
50,000 genomic loci due to the presence of five highly interactive
DNA-binding modules (i.e. PAI, RED, b-turn, linker and HD) in
the Pax3/4/6/7 protein subfamily that can recognize multiple
Figure 6. Pax6 regulates expression of Snca. (A) Identification of Pax6-binding region by ChIP-Chip in lens chromatin and corresponding
luciferase reporter constructs for transfection assays. (B) Pax6 regulates Snca promoter/distal region in cultured cells. Transient transfections were
performed in P19 embryonic carcinoma and in aTN4-1 lens cell as described in Methods. (C) Prediction of Pax6 binding sites with novel Pax6 DNA
binding motifs [48]. (D) EMSA validation of Pax6 binding to the probes identified by motif 1-1, 1-2 and 3-3. PD/HD, recombinant Pax6 protein
containing both Pax6 paired domain (PD) and homeodomain (HD). P6CON, DNA-binding concensus for Pax6 paired domain.
doi:10.1371/journal.pone.0054507.g006
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different binding sites, as we have shown earlier for Pax6 and its
splice variant Pax6(5a) [48]. In this regard, the number of Pax6-
bound genes in vivo could actually be higher than that reported
here, especially when one considers genes with Pax6-binding in
enhancer regions.
Genetic programs regulated by Pax6 in lens, forebrain
and other tissues
Although a number of known Pax6-direct target genes provide
molecular explanation of eye, forebrain and pancreas morpho-
genesis, the majority of genes controlled by Pax6 protein remain to
be identified. In the lens, Pax6 appears to control lens
development at multiple stages from the formation of lens lineage
[52], establishment of the lens placode [20], control of the lens
vesicle formation and its separation from the surface ectoderm
[22,23], regulation of cell cycle exit and differentiation of primary
lens fiber cells [25] to the control of lens fiber cell denucleation via
DNase IIb [26,65]. The present study adds six genes as novel
Pax6-direct target genes Gaa, Isl1, Kif1b,Mtmr2, Pcsk1n, and Snca in
the lens. A recent study has shown direct regulation of Pcsk1n by
Pax6 in pancreas [66]. Combinations of RNA expression profiling
with ChIP-chip studies and in situ hybridizations support the idea
that Pax6 also regulates Gaa, Kif1b and Snca in the embryonic
forebrain. Functions of Gaa, Kif1b and Snca have been
established outside of the lens. Gaa is a lysozomal enzyme highly
expressed in brain and its expression is increased in Pax6 mutant
forebrain [45]. The kinesin motor protein Kif1b functions in the
axonal transport of mitochondria and synaptic vesicles [67] and is
required for outgrowth of specific long axons in the peripheral and
central nervous systems [68]. Systematic studies of Kif1b as
microtubule-based molecular motor systems in lens fiber cell
elongation should open new research avenues onto this intricate
process. Snca encodes a-synuclein, which regulates dopamine
release and transport [69,70,71] and contributes to cognitive
function [72]. Different regulation of Snca by Pax6 in lens and
cortex is likely caused by different cell-specific contexts. The
repressive function of Pax6 on Snca promoter/enhancer system in
cultured lens cells requires the presence of Pax6 C-terminal
domain. The repressor complexes bound to Pax6 through this
subdomain remain to be identified.
Mutations in KIF1B and SNCA cause human diseases affecting
the central nervous system. Human GAA mutations cause
glycogen storage disease type II (Pompe’s disease), manifestated
by muscular dystrophy [73]. A single report of human aborted
fetus identified large glycogen deposits within the eye excluding
the iris epithelium and retinal pigmented epithelium [74].
Mutations in human KIF1B cause Charcot-Marie-Tooth disease
type 2A [75] and have been linked to multiple sclerosis [76].
Finally, mutations in SNCA cause Parkinson’s disease and Lewy
body disease. Thus, it is possible that deregulation of GAA, KIF1B
and SNCA is involved in pathology of human PAX6 patients with
a range of neurological disorders including autism [77,78,79],
cognitive disorders [80], epilepsy [81] and mental retardation [77].
In the lens placode, the present data suggest Dsp, Dusp6, Efnb2,
Fat4, Has2, Nav1 and Trpm3, as candidates for direct regulation
by Pax6 with a range of potential functions in lens morphogenesis
(Figure 8). Their Pax6-binding regions, identified by ChIP-chip
studies, are shown in Figure S2. Dsp is an important component of
cell-cell junction system in lens fibers [82,83]. Dusp6 serves as a
negative regulator of FGF/MAPK/Ras signaling [84], a key signal
transduction pathway with multiple roles in lens lineage formation
and lens fiber cell differentiation [85]. Ephrin-B2 (Efnb2), EPH-
related receptor tyrosine kinase ligand 5, is specifically expressed in
lens epithelium [86]. Similar proteins, Ephrin-A5 and EphA2, play
a number of important roles in lens development and cataracto-
genesis [87]. Ephrins, including Efnb2, genetically interact with
the Reelin pathway and control neuronal migration [88]. It has
been shown in kidney, that Fat4 is a component of hippo signaling
and important for planar cell polarity [89]; recent studies
established roles of Wnt/planar cell polarity signaling in lens
Figure 7. Down-regulation of Kif1b and Snca in Sye/Sey forebrains. In situ hybridization analysis of E14 wild type (WT) and Pax6Sey/Sey mouse
embryos. Ganglionic eminence, GE.
doi:10.1371/journal.pone.0054507.g007
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morphogenesis [90] and components of the Hippo pathway in
regulating lens fiber cell terminal differentiation [91]. Hyaluronan
synthase Has2 is a glycosyltransferase that catalyze polymerization
of hyaluronan found in both intra- and extracellular compart-
ments that protect epithelial cell integrity [92,93]. Expression of
Has2 was shown in the lens pit [94] and is an excellent candidate
to better understand the molecular mechanisms of lens placode
formation and its invagination [95,96] as Has2 has been recently
implicated in the otic placode morphogenesis as a FGF-regulated
gene [97]. Nav1 is microtubule-associated protein involved in
neuronal migration [98]. Given a number of similarities between
genes regulated by Pax6 in lens and neuronal development [26],
Nav1 may play similar roles in lens differentiation. Ingenuity
Pathway Analysis performed on this gene set identified a hub
comprised of three genes, Stat3 (down-regulated in the Pax6
mutated embryos), Tnf (occupied by Pax6 in lens chromatin) and
EGFR/Erbb2 that link together downstream functions of Dsp,
Dusp6, Efnb2 and Has2 (Figure 8). Future experiments to probe
functions of these Pax6-regulated genes and precise identification
of Pax6-binding sites within their regulatory regions will shed new
light into the process of lens morphogenesis.
The RNA expression profiling analysis of wild type and Pax6
mutated embryos revealed several hundreds of novel transcripts
whose expression is dependent on Pax6 during the formation of
lens placode. Several examples (Figure 3A) deserve additional
comments. Expression of Dnmt3a, an essential de novo DNA
methylase [99], is not only reduced in Pax6 mutant surface
ectoderm, but also in Pax6-deficient optic vesicles/forebrains
isolated from E9.5 embryos [100]. Dnmt3a is expressed in E11.5
lens [101]. In contrast, expression of cB-crystallin (Crygb) and
Nav1 is reduced in Pax6-deficient surface ectoderm but increased
in mutant optic vesicles [100]. Both Dkk3 and Sfrp2 function as
negative regulators of Wnt/b-catenin signaling [102]. Expression
of Dkk3 is reduced in E12 Pax6 mutated cortex [45] and directly
regulated by Pax6 [103]. The regulation of three canonical Wnt
signaling modulators, Dkk1, Sfrp1 and Sfrp2, through Pax6 has
already been shown in lens and during neurogenesis [54].
Expression of Cdh7 and Wnt5a is also Pax6-dependent in rat
embryonic hindbrain [104]. In pancreas, both c-Maf and MafB
(Figure 3A) were shown as Pax6-direct target genes [36]. In
conclusion, considering the multitude of roles played by Pax6 in
embryonic development through the control of cell lineage
formation, cellular differentiation, neuronal and ocular stem cell
biology [105,106,107] and tissue regeneration [108], future studies
will require integration of the ChIP-seq and RNA expression
profiling using smaller amounts of chromatin to elucidate function
of this regulatory protein at different stages of embryonic
development and at different stages. This will allow expanded
reconstruction of gene regulatory networks (GRNs) under the
genetic control of Pax6, including identification of unique
pathways and those shared between two or more distinct cell types.
Conclusions
Our results demonstrate that Pax6 interacts preferentially with
,8.5 kb promoter regions examined through high density
oligonucleotide arrays in a tissue-specific fashion though ,20%
of the regions identified are accessible to Pax6 in at least two
tissues examined, i.e. lens, embryonic cortex and cultured
pancreatic b-cells. Two combinations of ChIP-chip and RNA
expression profiling in Pax6 mutated tissues suggest eleven novel
direct targets of Pax6 in the lens. Six of these genes: Gaa, Isl1,
Kif1b, Mtmr2, Pcsk1n, and Snca, were confirmed by studies in the
newborn lens chromatin. Additional data indicate that Pax6 also
regulates Kif1b and Snca in the embryonic forebrain. Collectively,
these results provide new insights into the process of embryonic
lens formation, reveal common Pax6-dependent pathways during
lens and neuronal differentiation, and open new research avenues
to dissect the Pax6-regulated processes at the molecular level.
Materials and Methods
Ethics Statement
Animal husbandry and experiments were performed following
the approved protocol of the Albert Einstein College of Medicine
Animal Institute Committee and the Association for Research in
Vision and Ophthalmology (ARVO) for the use of experimental
animals in ophthalmic and vision research.
Cells and tissues
Lenses were isolated from newborn mice (strain CD-1),
forebrains were obtained from E15.5 embryos, mouse bT3
pancreas cells were cultured as described elsewhere [109], Pax6-
positive cortical progenitor cells (CA-5) were differentiated from
mouse ES cells as described elsewhere [55]. The materials were
stored in RNA Later (Ambion, Woodlands, TX).
Figure 8. Diagrammatic summary of novel functions of Pax6 during lens development. The connections between genes regulated by
Pax6 in lens placode were identified via Ingenuity Pathway Analysis (IPA) (Ingenuity Systems, Mountain View, CA). Expression of Stat3 is reduced in
the Pax6 mutated E9.5 embryonic tissues. The Tnf promoter region is occupied by Pax6 in lens chromatin.
doi:10.1371/journal.pone.0054507.g008
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Oligonucleotide microarrays and mRNA expression
profiling
RNA isolations were performed using the RNeasy MiniElute
Kit and RNase-Free DNase set (QIAGEN, Valencia, CA). RNA
quality was assessed using the Agilent 2100 Bioanalyzer with the
Nano LabChip Kit (Agilent Technologies; Palo Alto, CA).
Replicate sets of RNAs from mouse ES cells, Pax6-positive
cortical progenitor cells, E15.5 forebrain, newborn lens and
cultured bT3-cells (n = 3) were prepared for microarray analyses.
cDNA synthesis and amplifications were performed with the
Ovation TM RNA Amplification System V2 (Nugen, San Carlos,
CA) using 50 ng of total RNA per sample. Amplified cDNAs were
cleaned and purified with the DNA clean and Concentrator TM-25
kit (Zymo Research, Orange, CA). Fragmentation and labeling
was performed using the FL Ovation TM cDNA Biotin Module V2
(Nugen, San Carlos, CA) according to manufacturer’s instructions.
The samples were subsequently hybridized on Mouse Genome
430A 2.0 Arrays (Affymetrix, Santa Clara, CA) following the
manufacturer’s specification.
Laser microdissections were conducted on sections prepared
from E9.5 wild type and Pax6 null embryos followed by cDNA
analysis via Illumina Mouse WG-6 V1 1 R4 expression BeadChips
as described elsewhere [96]. Three sets of biological replicate
experiments (E9.5), each comprised from independent triplicates,
were entered into the initial analysis of the differentially expressed
genes. In addition, we used additional triplicate experiment
generated using E10.5 mouse embryos. The raw intensities were
generated by the array scanner; the fold change (FC) calculations
were based on median centered, baseline (WT) normalized data
where the negative values (detected upon scanning as lower than
the array background) were trimmed to the minimum intensity
unit equal to 1. The KO FC calculations were expressed as the
median FC value in the KO samples divided by the median FC in
the WT samples as shown in Fig. 3A. Illumina GenomeStudio Diff
Score thresholds (i.e. default program recommended by Illumina
to analyze differential abundance of these arrays) were applied to
this dataset as well to additional two independent triplicate
datasets. This procedure includes log transformation and generates
a Diff Score, a measure of transformation of the p-value that
provides directionality to the p-value based on the difference
between the average signal in the reference group vs. the
comparison group. The numbers were generated at DiffScore
613 corresponding to p-value,0.05. Expression of 27 individual
genes was evaluated using all four biological triplicates (12 mutants
vs. 12 wild types) by Illumina GenomeStudio Diff Score
thresholds.
ChIP-chip and qChIP assays
Chromatin was prepared from E15.5 forebrain, newborn lens
and cultured bT3-cells, crosslinked and processed as described
earlier [26]. Three sets of biological replicates were performed
using each individual tissue. For the analysis, we used GeneChip
Mouse Promoter 1.0R Arrays (Affymetrix) with over 28,000
mouse promoters. The data were analyzed using Model-based
Analysis of Tiling-arrays [46], with the thresholds of MAT score of
4.0, fold-enrichment of 2, and 5% false discovery rate. The
‘‘Peaks’’ from MAT analysis were linked to individual genes using
Cis-regulatory Element Annotation System (CEAS) [110]. Vali-
dation of data via qChIP was performed using lens chromatin as
described elsewhere [48]. Pax6-binding regions were evaluated in
three independent lens chromatin preparations. Briefly, the
primers are designed for the ChIP-Chip peak regions and
surounding non-specific regions (NSRs). The amounts of each
specific DNA fragment in immunoprecipitates were determined by
quantitative PCR reactions using a standard curve generated for
each primer set with 0.04, 0.2, and 1% input DNA samples. The
enrichments obtained with IgG were subtracted from the
corresponding values obtained with anti-Pax6 antibody (Milli-
pore). To determine a critical value to distinguish real specific
binding signals from background noise, analysis of variance
(ANOVA) was first performed for the signals obtained from all
six NSRs and Cryaa +6 kb (negative controls), indicating no
significant differences among these NSRs. We then defined these
sites as the background group and performed a student t-test for
the background group. The results showed the 99% confidence
interval (CI) of the background signal value is 0.019,0.100,
indicating that all regions having signals higher than 0.100 should
be considered as specific Pax6-binding regions. The primer
sequences are listed in Table S2.
Bioinformatic tools
The GO and KEGG pathway functional annotations were
performed using the NIH web based tool DAVID (the Database
for Annotation, Visualization and Integrated Discovery) (http://
david.abcc.ncifcrf.gov/) [111]. Analysis of Pax6 DNA-binding
motifs was performed using FIMO (Find Individual Motif
Occurrences), a part of the MEME Suite software toolkit
(http://meme.sdsc.edu/meme/cgi-bin/fimo.cgi) [51].
Reporter plasmids and transient cotranfections
Wild type Pax6 expression clones in the pKW10 vector were
described earlier [112]. Three Pax6 missense (N50K, R128C,
R242T) and one nonsense (R317X) mutants are based on
naturally occurring mouse [113] and human [114,115,116]
mutations. The reporter plasmids contained homologous promot-
ers cloned in pGL3 (Promega). For studies of Gaa, Isl1, Kif1b,
Mtmr2, Pcsk1n and Snca, at least one distal region was cloned
either 59 or 39 of the promoter depending on its natural
localization in genome as shown in Figures 5, 6 and S2. The
individual regions were synthesized by GenScript or amplified by
PCR. Transient transfections were conducted by Lipofectamine
2000 (Invitrogen) in P19 embryonic carcinoma cells that do not
express endogenous Pax6 proteins [117] and in aTN4-1 lens
epithelium cells that express endogenous Pax6 proteins [118]. The
cells were co-transfected with 0.6 mg of firefly luciferase reporter
plasmids, 50 ng of the expression plasmid encoding Pax6 and
corresponding empty vector pKW10, and 20 ng of Renilla-TK
internal control using 24-well microplates. Dual-Luciferase
Reporter Assay System (Promega) was used according to the
manufacturer’s instructions.
RNA analysis: qRT-PCR and in situ hybridization
Relative expression levels of seven genes (Gaa, Isl1, Kif1b,Mtmr2,
Pax6, Pcsk1n, and Snca), identified in Pax6 heterozygous lenses,
and, six genes (Fat4, Trpm3, Pax6, Has2, Efnb2, and Nav1),
identified in Pax6 null ectoderms, were verified by qRT-PCR.
Total RNA from newborn wild type and Pax6+/2 littermates lens
were isolated using RNeasy MiniElute Kit and RNase-Free DNase
set (QIAGEN, Valencia, CA). Subsequently, cDNA was synthe-
sized with Random Hexamer primers (Invitrogen) and Superscript
TM III Reverse Transcriptase (Invitrogen), following manufac-
turer’s instruction. cDNA was diluted 10 times and qRT-PCR was
performed with Applied Biosystems (ABI, Foster City, CA)
7900HT fast Real-Time PCR system with Power SYBR Green
PCR master mix (ABI). For E9.5 embryos, the total RNA was
extracted from laser-capture dissected lens placodes. cDNA was
synthesized and amplified by OvationH Pico WTA Systems V2
(NUGEN). The quantitative Real-Time PCR was performed on
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Illunima ECO system with SYBR green for Nav1 and with
Taqman fluorescent probe method for other genes. Transcripts
encoding B2m (for new born lens) and Actb (for lens placode)
genes were used for normalization of expression levels of tested
genes in both wild type and mutant tissues as described earlier
[26,119]. Primers were designed using Primer 3 (http://frodo.wi.
mit.edu/cgi-bin/primer3) and the sequences are listed in Table
S2. In situ hybridization (ISH) analysis of Kif1b and Snca
employed probes generated using the primers summarized in
Table S2. ISHs were performed as previously described [120].
Supporting Information
Figure S1 RNA expression profiling of 133 genes commonly
occupied by Pax6 in three distinct chromatin sources. A) Principal
component analysis of five tissues/cells. Total RNA samples were
prepared from mouse embryonic stem cells (ESC, brown circles),
radial glia-progenitor cells differentiated from ESCs (CA-5, red
circles) [55], E15 embryonic cortex (blue circles), P1 lens (grey
circles), and b-cells (bT3-cell line, green circles) [109], and
subjected to analysis using the Mouse Genome 430 2.0 Arrays
(Affymetrix, Santa Clara, CA) as three biological replicates. B)
RNA expression profiling of 133 genes (see Figure 1A) in mouse
ES, Pax6-positive radial glia progenitors (CA-5), E15 forebrain/
cortex, newborn lens and b-cells. Hierarchical clustering of the
expression data was performed using GeneSpring 7.2 (Agilent
Technologies, Santa Clara, CA). Eight (Adprhl2, Cap1, Cma2,
Dpm2, Hook2, Rffl, Sra1 and Trove2 – regulated by Pax6 in E9.5 lens
placodes), three (Cenpn, Gaa and Snca – regulated by Pax6 in
newborn lens) and Otx2 (regulated by Pax6 in the optic cup) genes
are labeled by blue, green and black squares, respectively.
(TIF)
Figure S2 ChIP-chip results of Isl1, Mtmr2, Snca, Kif1b,
Pcskn1, Gaa and Dsp, Dusp6, Efnb2, Fat4, Has2, Nav1, Trpm3
in the chromatins of P1 lens, E15 cortex and b-cells.
(PDF)
Figure S3 A summary of Pax6-binding site motifs identified in
13 genes by both FIMO and mismatch searching. (A) Six target
genes indetified in Pax6+/2 lens (Gaa, Isl1, Kif1b, Mtmr2, Pcsk1n,
and Snca); and seven target genes in the lens placode (Dsp, Dusp6,
Efnb2, Fat4, Has2, Nav1 and Trpm3). The red highlighted
sequences were tested and validated in EMSA assay. (B) The
consensus sequences and stardards used for mismatch searching.
The mismatch searching was performed by online software
Fuzznuc (http://mobyle.pasteur.fr/).
(PDF)
Figure S4 IgG randomly binds to the genomic loci in qChIP
experiments. IgG (the same amount as Pax6 antibody) was used
for IP as a control in each of the three biological repeats of qChIP
experiments. While the specific enrichments of Pax6 binding at
particular genomic regions were repeatedly detected (Figure 4), the
non-specific binding by IgG are randomly distributed at the tested
genomic regions between the independent experiments.
(TIF)
Table S1 A compilation of genes occupied by Pax6 in chromatin
prepared from b-cells, forebrain and lens.
(XLS)
Table S2 Summary of oligonucleotides used in this study.
(PDF)
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